JACC: Heart Failure, 2020
Distinct Pathological Pathways in Patients With Heart Failure and Diabetes

Tromp J., Voors A., Sharma A. et al.

Leukemia Research, 2020
Plasma proteomics of biomarkers for inflammation or cancer cannot predict relapse in chronic myeloid leukaemia patients stopping tyrosine kinase inhibitor therapy

Söderlund S., Persson I., Ilander M. et al.

ESC Heart Failure, 2020
Biomarkers in patients with heart failure and central sleep apnoea: findings from the SERVE‐HF trial

Ferreira J., Duarte K., Woehrle H. et al.

RMD Open, 2020
Protein and DNA methylation-based scores as surrogate markers for interferon system activation in patients with primary Sjögren’s syndrome

Björk A., Richardsdotter Andersson E., Imgenberg-Kreuz J. et al.

ESC Heart Failure, 2020
Role of PCSK9 in the course of ejection fraction change after ST‐segment elevation myocardial infarction: a pilot study

Miñana G., Núñez J., Bayés‐Genís A. et al.

Inflammatory Bowel Diseases, 2020
Systemic Inflammatory Protein Profiles Distinguish Irritable Bowel Syndrome (IBS) and Ulcerative Colitis, Irrespective of Inflammation or IBS-Like Symptoms

Moraes L., Magnusson M., Mavroudis G. et al.

ESC Heart Failure, 2019
Prolargin and matrix metalloproteinase‐2 in heart failure after heart transplantation and their association with haemodynamics

Ahmed A., Ahmed S., Arvidsson M. et al.

BMJ Open Diabetes Research & Care, 2019
Deficiency of T cell CD40L has minor beneficial effects on obesity-induced metabolic dysfunction

Reiche M., den Toom M., Willemsen L. et al.

Nutrients, 2019
Exploring the Benefit of 2-Methylbutyric Acid in Patients Undergoing Hemodialysis Using a Cardiovascular Proteomics Approach

Wu P., Chiu Y., Zou H. et al.

Heliyon, 2019
Multi-biomarker panel signature as the key to diagnosis of ovarian cancer

Muinao T., Deka Boruah H., Pal M.

EP Europace, 2019
Atrial fibrillation progression risk factors and associated cardiovascular outcome in well-phenotyped patients: data from the AF-RISK study

De With R., Marcos E., Dudink E. et al.

Pulmonary Circulation, 2019
Matrix metalloproteinase 7 in diagnosis and differentiation of pulmonary arterial hypertension

Arvidsson M., Ahmed A., Bouzina H. et al.

Pulmonary Circulation, 2019
Higher plasma fibroblast growth factor 23 levels are associated with a higher risk profile in pulmonary arterial hypertension

Bouzina H., Hesselstrand R., Rådegran G.

Journal for ImmunoTherapy of Cancer, 2019
Peripheral immune-based biomarkers in cancer immunotherapy: can we realize their predictive potential?

Nixon A., Schalper K., Jacobs I. et al.

BMJ Open Diabetes Research & Care, 2019
Deficits in systemic biomarkers of neuroinflammation and growth factors promoting nerve regeneration in patients with type 2 diabetes and polyneuropathy

Ziegler D, Strom A, Bönhof GJ et al.

Investigative Opthalmology & Visual Science, 2019
Aqueous Humor Biomarkers Identify Three Prognostic Groups in Uveal Melanoma

Wierenga A., Cao J., Mouthaan H. et al.

Journal of Investigative Dermatology, 2019
Early Quantification of Systemic Inflammatory Proteins Predicts Long-Term Treatment Response to Tofacitinib and Etanercept

Tomalin L., Kim J., Correa da Rosa J. et al.

Frontiers in Oncology, 2019
Multi-platform Affinity Proteomics Identify Proteins Linked to Metastasis and Immune Suppression in Ovarian Cancer Plasma

Graumann J., Finkernagel F., Reinartz S. et al.

Thrombosis and Haemostasis, 2019
Longitudinally Measured Fibrinolysis Factors are Strong Predictors of Clinical Outcome in Patients with Chronic Heart Failure: The Bio-SHiFT Study

van den Berg V., Bouwens E., Umans V. et al.

Scientific Reports, 2019
Comparative analysis of obesity-related cardiometabolic and renal biomarkers in human plasma and serum

Rajan M., Sotak M., Barrenäs F. et al.